Page 361 - Effectiveness News Today

Two daughters went to public school, one thing that was consistent, ton of homework. i thought there was much more homework. they work, and everybody i talk to, i cant believe how much homework these kids had. i dont think they had it easy, and i dont -- i got to see where these targeted scores are and why theyre not producing results, but i think you have -- theres a mature saying is correct, too, is that, were putting a lot of money into these schools and its not necessarily democrat or republ...

>> the fda panel clearly recognized some serious urgency to support the patients that have gotten the j&j vaccine, but ultimately were not necessarily satisfied with all the options in front of them, so they went for a broader recommendation. >> reporter: data from johnson & johnson show a booster two months after the first shot increased protection against symptomatic disease to 94% and up to 100% against severe disease. and a more limited study showed a booster after six months produced up to ...

Two daughters went to public school, one thing that was consistent, ton of homework. i thought there was much more homework. they work, and everybody i talk to, i cant believe how much homework these kids had. i dont think they had it easy, and i dont -- i got to see where these targeted scores are and why theyre not producing results, but i think you have -- theres a mature saying is correct, too, is that, were putting a lot of money into these schools and its not necessarily democrat or republ...

Data. the top line data that we have is from the press releases from pfizer. looks like its great in terms of its effectiveness, in terms of the response. i also want to see the data. once the fda committee meets and the cdc meets and they provide the recommendation, im looking forward to getting my children vaccinated. we want to go back to normalish as soon as possible for our children as well. >> neil: i like that normaish. we dont know what that is anymore. but one thing about the booster pu...

Ought to be boosted. it needed a second shot sooner so that people could get to a higher -- a place of higher effectiveness to prevent getting sick from covid-19, so, again, with johnson & johnson, the recommendation is that if you are two months or more out, if you had your johnson & johnson shot at least two months ago and youre over 65, you have certain underlying medical conditions and its a very long list if you are a health care worker, if you are say in a nursing home, then you should be ...

The same for pfizer and moderna. the f.d.a. will formally decide on those boosters next week. the panel recommends pe g the j&j boosters two mon after their initialcination.teme covid caane thys than any organization, the head of the world health organization this week called the widespread use of booster shots immoral and unjust, until more people, he said, and people in the poorest countries get their first vaccinations. the biden administration, which is sending tens of millions of shots to p...

You reject a lawful order from congress. >> in every response, in his interview with joy reid, chairman thompson made it clear that the effectiveness of the committee is now all up to the attorney general of the united states. we >> look, january six joy, was awful. it was not a movement, people saw it in realtime, they saw it with their own tie eyes. and so we have been tasked with the responsibility of crafting a solution. mayor garland, has to do his job in a timely manner. in order for us to...

Essentially they said the johnson & johnson vaccine, we know its not as effective as pfizer and moderna at least initially. data is showing its effectiveness stays fairly even over time. doesnt drop off. a better way to explain. pfizer and moderna, a high peak. peak up readily. johnson & johnson not quite as high. but that johnson & johnson stays pretty constant, whereas pfizer and moderna dip down over a six to eight-month period. saying we need boosters for pfizer and moderna. talk about the b...

Inquisitive about what information i knew about the vaccines and their effectiveness and safety. so it was just really a conversation, communication we were both trying to understand each others point of view. literally it was a debate. it was sort of a point, counterpoint discussion around information related to the vaccines. but i think we were both genuinely interested in hearing out what the other person had to say and their point of view. >> thats so interesting. i think so much is lost in ...

Neutralizing antibody and other immune responses clearly benefitted from that second dose. so i was actually surprised when it came out as a one-dose vaccine. so i think this is kind of an auto correction and a welcome one. the two-month concept is based on the fact that their large phase 3 clinical trial on the two doses was done 56 days apart and it looked really good. it increased vaccine effectiveness from 60 to 70% to over 90%. so i think thats probably where the two-dose idea comes from. t...